Endurant Capital Management LP Bolt Biotherapeutics, Inc. Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.19 - $13.97 $377,271 - $1.26 Million
-90,041 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$11.15 - $18.6 $1 Million - $1.67 Million
90,041 New
90,041 $1.14 Million
Q2 2021

Aug 16, 2021
SELL
$15.4 - $31.46 $273,765 - $559,264
-17,777 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$25.86 - $39.93 $459,713 - $709,835
17,777 New
17,777 $585,000

Others Institutions Holding BOLT

# of Institutions
37
Shares Held
22.8M
Call Options Held
0
Put Options Held
0
View Full List

About Bolt Biotherapeutics, Inc.

BOLT Quotes by TradingView
  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $24.1M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email